Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Oesophago-gastric Cancer × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 385 Carcinoma, Hepatocellular 228 Stomach Neoplasms 220 Rectal Neoplasms 189 Colonic Neoplasms 180 Pancreatic Neoplasms 156 Esophageal Neoplasms 102 Liver Neoplasms 68 Neoplasm Metastasis 66 Esophageal Squamous Cell Carcinoma 60 Neoplasms 59 Gastrointestinal Stromal Tumors 32 Cholangiocarcinoma 31 Gastrointestinal Neoplasms 28 Gallbladder Neoplasms 23 Adenocarcinoma Of Esophagus 22 Parkinson Disease 4, Autosomal Dominant Lewy Body 20 Biliary Tract Neoplasms 20 Anus Neoplasms 20 Recurrence 19 Adenocarcinoma 19 Bile Duct Neoplasms 18 Digestive System Neoplasms 15 Breast Neoplasms 14 Lung Neoplasms 12 Uterine Cervical Neoplasms 11 Prostatic Neoplasms 11 Carcinoma 11 Digestive System Diseases 10 Carcinoma, Non-Small-Cell Lung 9

Interventions

Panitumumab 1 Oxaliplatin 1 Epirubicin 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00824785 2012-12-11

REAL3

Royal Marsden NHS Foundation Trust

Phase 3 Terminated

Gastrointestinal

Oesophago-gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡